Light Mode
$0.0400 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0400, and at the day’s high of $0.0411
+0.00 (+7.82%) / 6M
Momentum, market sentiment, and recent alerts
AGTX reads n/a: the 12-month move is -10.5%.
No alerts for AGTX in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Agentix Corp.is a biotechnology company, which engages in the development and commercialization of novel therapeutics to treat metabolic diseases, peripheral neuropathy, progressive lung disease, and ischemic reperfusion injury. It is focused on the development of synthetic agonists, inverse agonists, and antagonists which modulate the endocannabinoid system (ECS). The company was founded on April 18, 2013 and is headquartered in Dana Point, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.